2TE-16784-42547
3 vaccinations
2 coded responses
2 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 16-20
- ZIP prefix
- 750 / TX
- Registered
- 2022-04-11
- Relationship
- Child or adolescent in my care
- Guardian
- Y8N-33869-56939
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-23
Dose 2 — Pfizer-BioNTech
-
2021-12-22
Dose 3 — Pfizer-BioNTech
-
2022-04-11
Registered in v-safe
-
2022-06-22
Survey response — 6 months, dose 3, dependentMedDRA: Cough, Nasal congestion — Feeling: GoodFree text: Chronic nasal congestion and cough that lasted a few weeks during May.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Survey response — 12 months, dose 3, dependentMedDRA: Influenza — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: FluMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | No |
| 2 | 2021-03-23 | Pfizer-BioNTech | No |
| 3 | 2021-12-22 | Pfizer-BioNTech | No |
Free text
Release 12 — 6 months, dose 3, dependent
Symptoms: Chronic nasal congestion and cough that lasted a few weeks during May.
Release 12 — 12 months, dose 3, dependent
Symptoms: Flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release